Al-Razi Medical Co.

9572.SRSAUHealthcare● Active

$29.22

+$0.90(+3.18%)

Market Cap$44414400

P/E Ratio—

52W High$45.7

52W Low$25.1

Avg Volume6K

Open$29.50

Beta0.35

PE Ratio Market Cap Forecast

Al-Razi Medical Co. (9572.SR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

9572.sr · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Al-Razi Medical Co. (9572.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9572.SR's current PE ratio of 54.09x is calculated by dividing its stock price of $29.22 by its TTM earnings per share of $0.54. −63.1% discount vs 5Y avg 146.7x

54.09x

P/E Ratio (TTM)−63.1%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

N/A

—

EPS (TTM)

$0.54

TTM · diluted EPS

PEG Ratio

0.15

Below 1.0 · Growth adjusted

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Al-Razi Medical Co. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-15

PE Ratio History

2021 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 146.7x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 5 fiscal years · Front-end computed

Average

146.7x

5-yr mean

Median

56.5x

5-yr midpoint

Minimum

25.6x

Lowest year

Maximum

491.7x

Highest year

54.1x ← Now

25.6x
MinQ1 · 25%56.5x
MedianQ3 · 75%491.7x
Max

Within Historical Range

At 54.09x, 9572.SR's current P/E is within its average historical range over the past 5 fiscal years.

40th percentileHigher than 2 of 5 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

Annual PE Ratio History

Showing 5 of 5 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	56.50x	$0.54	-88.5%
2024-12-31 FY2024	491.67x	$0.12	+271.0%
2023-12-31 FY2023	132.51x	$0.45	+382.4%
2022-12-31 FY2022	27.47x	$1.33	+7.4%
2021-12-31 FY2021	25.58x	$1.42	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $29.22 ÷ $0.54 = 54.09x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

9572.SR pe ratio · 6 questions

9572.SR's current PE ratio is 54.09x as of 2026-06-15, based on a stock price of $29.22 and TTM EPS of $0.54. Data sourced from Financial Modeling Prep via 9572.SR's SEC 10-K and 10-Q filings.

9572.SR PE ratioWhat is 9572.SR PE ratioCurrent PE ratio of 9572.SR9572.SR PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Al-Razi Medical Co. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15